RADAR-CNS: Remote Assessment of Disease and Relapse – Central Nervous System

A collaborative research programme that explored the potential of wearable devices to help measure and predict clinical outcomes in depression, MS and epilepsy

Arrow RightAbout Arrow RightResults Arrow RightVideos Arrow RightRADAR-base

RADAR-CNS

A collaborative research programme that explored the potential of wearable devices to help measure and predict clinical outcomes in depression, MS and epilepsy

RADAR-CNS was a major new research programme that developed new ways of monitoring major depressive disorder, epilepsy, and multiple sclerosis using wearable devices and smartphone technology. 

RADAR-CNS was jointly led by King’s College London and Janssen Pharmaceutica NV, funded by the Innovative Medicines Initiative (a Public Private Partnership established between the European Federation of Pharmaceutical Industries and Associations (EFPIA) and the European Union) and involved 22 organisations from across Europe and the US. The programme ran from 2016 to 2022. 

 

Share this page…